http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2208522-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2227a4ee4bf2e2b230299ca24fd3308a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B55-00
filingDate 1996-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a95192415d7fdab8c91783d28c9ed87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff1e4e7b0b5d2874b3926d73fc74ac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9d2c6dc17f8fd91e89d947d8515981
publicationDate 2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2208522-C
titleOfInvention Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
abstract An optically-enriched piperidine-2-carboxanilide compound, in which the piperidine is optionally N-alkylated, is racemised by heating the compound in an aqueous medium, provided that the medium includes an organic cosolvent if the compound is N-alkylated. This process is particularly valuable, in conjuction with a resolution process, for the manufacture of levobupivacaine.
priorityDate 1995-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426154099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10014180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53262295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415987206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451107134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421350379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547

Total number of triples: 43.